- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Growth Potential Companies
Global Pharmaceuticals & Biotech High Growth Potential Companies
Results
509
Companies with a Future performance score of at least 3, ordered by Future performance score.
509 companies
Immunic
Market Cap: US$88.0m
A biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.
IMUX
US$0.99
7D
10.4%
1Y
-22.8%
Genenta Science
Market Cap: US$69.3m
A clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.
GNTA
US$3.83
7D
7.5%
1Y
11.5%
Charles River Laboratories International
Market Cap: US$5.2b
Charles River Laboratories International, Inc.
CRL
US$105.92
7D
-14.3%
1Y
-54.4%
Guard Therapeutics International
Market Cap: SEK 244.0m
A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.
GUARD
SEK 12.10
7D
-1.2%
1Y
-55.2%
Lipum
Market Cap: SEK 318.2m
A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.
LIPUM
SEK 15.00
7D
0%
1Y
106.9%